Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03096860 · ClinicalTrials.gov registry record · NA
Effect of Concurrent Hookah and Alcohol Consumption on Smoking Topography and Toxicant Exposure
A NA study, sponsored by Oklahoma State University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03096860: Completed NA study, sponsored by Oklahoma State University.
NCT03096860 is a NA study that has completed, run by Oklahoma State University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03096860, a NA study, has completed, sponsored by Oklahoma State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of the current study is to investigate in a prospective randomized cross-over trial, the impact of alcohol versus a placebo drink on smoking behavior and topography (duration and frequency of puffing), abuse liability, and toxicity. It is hypothesized that drinking alcohol before smoking will be associated with longer puffs and shorter duration between puffs and greater abuse liability and toxicity.
Primary Outcome
hookah topography
Interventions
- OTHER Active alcohol consumption
- OTHER Placebo consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2017-10-10 |
| Phase | NA |
What the finished NCT03096860 record still lists
NCT03096860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Active alcohol consumption is the first listed.
NCT03096860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03096860 about?
NCT03096860 is a clinical study titled "Effect of Concurrent Hookah and Alcohol Consumption on Smoking Topography and Toxicant Exposure". The purpose of the current study is to investigate in a prospective randomized cross-over trial, the impact of alcohol versus a placebo drink on smoking behavior and topography (duration and frequency of puffing), abuse liability, and toxicity. It is hypothesized that drinking alcohol before smoking...
What is the current status of trial NCT03096860?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-02-22. Estimated completion is 2017-10-10.
What interventions are being tested in trial NCT03096860?
The interventions under investigation include: Active alcohol consumption (OTHER), Placebo consumption (OTHER).
Who is sponsoring clinical trial NCT03096860?
This trial is sponsored by Oklahoma State University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03096860's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI